Fig. 1From: Molecular profiling of hormone receptor-positive, HER2-negative breast cancers from patients treated with neoadjuvant endocrine therapy in the CARMINA 02 trial (UCBG-0609)Flow-chart of data processing and analysis. BMI body mass indexBack to article page